SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-001164
Filing Date
2018-01-08
Accepted
2018-01-08 06:08:12
Documents
20
Period of Report
2018-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv482843_8k.htm 8-K 17267
2 EXHIBIT 99.1 tv482843_ex99-1.htm EX-99.1 21142
3 GRAPHIC image_001.jpg GRAPHIC 264234
4 GRAPHIC image_002.jpg GRAPHIC 194552
5 GRAPHIC image_003.jpg GRAPHIC 245317
6 GRAPHIC image_004.jpg GRAPHIC 188574
7 GRAPHIC image_005.jpg GRAPHIC 147061
8 GRAPHIC image_006.jpg GRAPHIC 192877
9 GRAPHIC image_007.jpg GRAPHIC 221239
10 GRAPHIC image_008.jpg GRAPHIC 290162
11 GRAPHIC image_009.jpg GRAPHIC 312312
12 GRAPHIC image_010.jpg GRAPHIC 201774
13 GRAPHIC image_011.jpg GRAPHIC 199589
14 GRAPHIC image_012.jpg GRAPHIC 178427
15 GRAPHIC image_013.jpg GRAPHIC 166137
16 GRAPHIC image_014.jpg GRAPHIC 227967
17 GRAPHIC image_015.jpg GRAPHIC 191954
18 GRAPHIC image_016.jpg GRAPHIC 264812
19 GRAPHIC image_017.jpg GRAPHIC 153407
20 GRAPHIC image_018.jpg GRAPHIC 176649
  Complete submission text file 0001144204-18-001164.txt   5298806
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 18514745
SIC: 2836 Biological Products, (No Diagnostic Substances)